Table 1.

Clinical and Demographic Characteristics of the Samples (n = 212)

Characteristics	Sample (n = 212)
Age (years)	24.9±10.0
Gender
Male/female	126/86
Baseline weight (kg)	58.13±12.85
Weight after 6 months (kg)	60.38±13.74
Baseline BMI (kg/m2)	21.42±3.38
BMI after 6 months (kg/m2)	22.17±3.73
Drug prescribed
VPA monotherapy	121
VPA+LTG	72
VPA+CBZ	12
VPA+OXC	7
Dosage of VPA (mg/day)	200–1250
VPA Css (μg/mL)	58.4±25.4

CBZ, carbamazepine; Css, steady state plasma concentrations; LTG, lamotrigine; OXC, oxcarbazepine; VPA, valproic acid.